z-logo
open-access-imgOpen Access
Definition of Platelet-Derived Histamine-Releasing Factor and Histaminergic Receptors Modulating Platelet Aggregation
Author(s) -
P. F. Mannaioni,
Alessandra Pistelli,
Francesco Gambassi,
M. G. Di Bello,
S. Raspanti,
Emanuela Masini
Publication year - 1991
Publication title -
international archives of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.696
H-Index - 100
eISSN - 1423-0097
pISSN - 1018-2438
DOI - 10.1159/000235391
Subject(s) - mepyramine , histamine , platelet , histaminergic , chemistry , mast cell , thrombin , histamine h1 receptor , histamine h2 receptor , receptor , pharmacology , endogeny , platelet activating factor , endocrinology , medicine , immunology , biochemistry , biology , antagonist
Endogenous and exogenous free radical scavengers significantly decrease mast cell histamine release induced by coincubation with resting, activated platelets or with platelet-derived supernatant. Histamine and pyridylethylamine dose-dependently enhance platelet aggregation; the effect is potentiated by ranitidine and blocked by mepyramine. Histamine increases also cytosolic calcium concentration in platelets stimulated with thrombin, and binding sites for [3H]-mepyramine are present on platelet membranes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom